Form 8-K - Current report:
SEC Accession No. 0001564590-22-012684
Filing Date
2022-03-30
Accepted
2022-03-30 17:21:05
Documents
17
Period of Report
2022-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PROJECT GIANTS PRICING 8-K gern-8k_20220329.htm   iXBRL 8-K 47972
2 EX-1.1 gern-ex11_9.htm EX-1.1 220185
3 EX-4.1 gern-ex41_8.htm EX-4.1 141427
4 EX-4.2 gern-ex42_7.htm EX-4.2 197252
5 EX-5.1 gern-ex51_6.htm EX-5.1 17202
6 GRAPHIC g5zjdddyvqfn000001.jpg GRAPHIC 631
  Complete submission text file 0001564590-22-012684.txt   867651

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA gern-20220329.xsd EX-101.SCH 5609
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20220329_lab.xml EX-101.LAB 19431
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20220329_pre.xml EX-101.PRE 11504
11 EXTRACTED XBRL INSTANCE DOCUMENT gern-8k_20220329_htm.xml XML 3546
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 22787788
SIC: 2834 Pharmaceutical Preparations